- Trastuzumab, sold
under the
brand name
Herceptin among others, is a
monoclonal antibody used to
treat breast cancer and
stomach cancer. It is specifically...
- Trastuzumab/hyaluronidase, sold
under the
brand name
Herceptin SC
among others, is a fixed-dose
combination medication for the
treatment of HER2-overexpressing...
- (pla**** by
Harry Connick Jr.), who
helped develop the
breast cancer drug
Herceptin, over the
course of 8
years from 1988 to 1996. Dr.
Slamon is a physician...
- non-Hodgkin's lymphomas. In 2006, also
approved for
rheumatoid arthritis. 1998:
Herceptin (trastuzumab):
Treatment for
metastatic breast cancer patients with tumors...
- TCH is a
chemotherapy regimen consisting of
Taxotere (docetaxel),
carboplatin and
Herceptin (trastuzumab),
which is used to
treat breast cancer. v t e...
-
Archived from the
original on
October 5, 2023.
Retrieved March 7, 2024. "
Herceptin EPAR".
European Medicines Agency (EMA).
Archived from the
original on...
- he
shared with
Dennis Slamon and Axel
Ullrich for
their development of
Herceptin Shepherd holds a bachelor's
degree from the
University of California,...
-
conjugate consisting of the
humanized monoclonal antibody trastuzumab (
Herceptin)
covalently linked to the
topoisomerase I
inhibitor deruxtecan (a derivative...
-
conjugate consisting of the
humanized monoclonal antibody trastuzumab (
Herceptin)
covalently linked to the
cytotoxic agent DM1.
Trastuzumab alone stops...
- D,
Gutheil JC,
Harris LN,
Fehrenbacher L, et al. (2001). "First-line
Herceptin monotherapy in
metastatic breast cancer". Oncology. 61. 61 (Suppl. 2):...
